Cargando…
Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers
PURPOSE: Colorectal cancer (CRC) is the third most frequently diagnosed cancer and the fourth leading cause of cancer death over the world. Nano-sized drug delivery systems are used for the treatment of cancers. The aim of this study was to develop a tangeretin (TAGE) and atorvastatin (ATST) combine...
Autores principales: | Bao, He, Zheng, Nanbo, Li, Zhuanting, Zhi, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397562/ https://www.ncbi.nlm.nih.gov/pubmed/32801644 http://dx.doi.org/10.2147/DDDT.S256636 |
Ejemplares similares
-
Targeted Delivery of Doxorubicin by Folic Acid-Decorated
Dual Functional Nanocarrier
por: Lu, Jianqin, et al.
Publicado: (2014) -
Correction to “Targeted Delivery of Doxorubicin
by Folic Acid-Decorated Dual Functional Nanocarrier”
por: Lu, Jianqin, et al.
Publicado: (2019) -
An iRGD peptide conjugated heparin nanocarrier for gastric cancer therapy
por: Ai, Shichao, et al.
Publicado: (2018) -
Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery
por: Yu, Xiaolin, et al.
Publicado: (2021) -
A novel local anesthetic system: transcriptional transactivator peptide-decorated nanocarriers for skin delivery of ropivacaine
por: Chen, Chuanyu, et al.
Publicado: (2017)